It turned out that in regular coffee drinkers, a good number of these adenosine receptors were blocked by caffeine when the people were infused with it.
The Glaxo gene therapy program will focus on a severe immune deficiency called ADA-SCID, in which kids cannot make a crucial enzyme called adenosine deaminase that is needed to create immune system cells.